)
Clene (CLNN) investor relations material
Clene Emerging Growth Conference 89 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Regulatory progress and clinical data
Granted an in-person Type C FDA meeting this quarter to discuss biomarker and survival data for ALS treatment.
Biomarker analyses showed significant reductions in neurofilament and GFAP, both linked to longer survival in ALS patients.
Survival benefit consistently demonstrated across multiple data sets, despite missing the ALSFRS functional endpoint in the HEALEY study.
Data package includes three key biomarkers: neurofilament, GFAP, and IGFBP, all showing concordant responses and association with survival.
Plan to file a New Drug Application for accelerated approval if FDA concurs, targeting submission in Q2 and potential commercialization early next year.
Accelerated approval pathway and next steps
Accelerated approval pathway pursued using biomarker as surrogate endpoint, following precedent set by Biogen's Tofersen.
Confirmatory phase III study planned, focusing on survival as the primary endpoint.
FDA meeting scheduled for later this quarter, with outcome determining NDA filing timeline.
If NDA is accepted, potential FDA decision and commercialization could occur by early next year.
Financial update and investor participation
Recent tranche financing raised $6 million at $6.50 per share, extending cash runway by an additional quarter.
Additional tranches could raise $7 million at $7 and $15 million at $12.50, triggered by regulatory milestones.
Three major healthcare investors participated: Vivo, Castellan, and Boxer Capital.
Funding now supports operations through potential approval in a positive scenario.
Next Clene earnings date
Next Clene earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)